XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity (Details)
$ / shares in Units, $ in Millions, $ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2022
shares
Sep. 30, 2022
CAD ($)
$ / shares
shares
Jun. 30, 2022
shares
Mar. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
shares
Sep. 30, 2021
shares
Jun. 30, 2021
CAD ($)
$ / shares
shares
Mar. 31, 2021
Jun. 30, 2022
shares
Jun. 30, 2021
CAD ($)
$ / shares
shares
Jun. 30, 2020
CAD ($)
$ / shares
shares
Sep. 30, 2022
CAD ($)
$ / shares
shares
Sep. 30, 2021
CAD ($)
shares
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2020
CAD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
Shareholders' Equity (Details) [Line Items]                                
Agreement, description               the Company entered into a new agreement with two securities dealers, for an At-The-Market offering program, entitling the Company, at its discretion, and from time to time, to sell up to US$75 million in value of common shares of the Company. This program can be in effect until the Company’s current US$775 million Shelf Registration Statement expires in January 2023. In 2021, the Company issued 2,242,112 shares, at an average selling price of $22.71 per share, for net proceeds of $49.9 million under the Company’s At-The-Market offering. During the nine months ended September 30, 2022, the Company issued 997,508 shares, at an average selling price of $22.83 per share, for net proceeds of $22.3 million under the Company’s At-The-Market offering.                
Common shares issued (in Shares) | shares   55,322                   55,322        
Share premium       $ 0.1 $ 2.2                 $ 2.2 $ 1.6  
Exploration expenditures       0.2                   6.5 $ 4.7  
Expiration of share options, description                       The outstanding share options at September 30, 2022 expire on various dates between December 2022 and June 2024.        
Exercised options (in Shares) | shares                       186,007        
Proceeds amount                       $ 2.7        
Common shares issued (in Shares) | shares   186,007                   186,007        
Weighted average share price exercise options (in Dollars per share) | $ / shares   $ 23.47                   $ 23.47        
Fair value grants         2.6                      
Fair value grants amortized         0.4             $ 0.1        
Common shares exchanged (in Shares) | shares                 119,800              
Basic and diluted net income                       $ 25.4 $ 9.4      
Total stock options (in Shares) | shares                       737,327 1,814,167      
Restricted stock units outstanding (in Shares) | shares                       25,000      
Equity Financing [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Value of common shares (in Dollars)                               $ 40
Common shares issued (in Shares) | shares             350,000     350,000 345,000       1,327,046  
Price per share (in Dollars per share) | $ / shares             $ 28.06     $ 28.06 $ 32.94       $ 21.94  
Net proceeds                             $ 28.5  
Gross proceeds                   $ 9.8 $ 11.4          
Share premium   $ 0.9     $ 0.2   $ 1.5     $ 1.5 $ 3.9 $ 0.9   0.2    
Exploration expenditures                       6.1   $ 1.1    
RSU [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Restricted share units granted (in Shares) | shares                           123,800    
Restricted stock units, description                           Of these, 28,000 RSUs were granted to Board members, 75,200 RSUs were granted to members of senior management, and the remaining 20,600 RSUs were granted to other employees of the Company.    
Fair value grants                           $ 2.6    
Fair value grants amortized       $ 2.2               0.5        
Restricted share units vested (in Shares) | shares                 128,800              
Restricted share units granted (in Shares) | shares         40,000 40,000                    
Board Members [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Restricted stock units vested (in Shares) | shares     5,000                          
Board Members [Member] | RSU [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Fair value grants             $ 0.2                  
Restricted stock units granted (in Shares) | shares             10,000                  
Board [Member] | RSU [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Fair value grants                       $ 0.9        
Restricted stock units vested (in Shares) | shares   20,000,000,000                            
Non-adjusting events after reporting period [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Exercised options (in Shares) | shares 100,000                              
Stock options and Restricted share units [Member]                                
Shareholders' Equity (Details) [Line Items]                                
Stock options term                       5 years